Provided by Tiger Trade Technology Pte. Ltd.

Kenvue Inc

19.30
-0.0350-0.18%
Volume:15.38M
Turnover:297.84M
Market Cap:36.97B
PE:22.70
High:19.47
Open:19.43
Low:19.27
Close:19.33
52wk High:21.40
52wk Low:14.02
Shares:1.92B
Float Shares:1.89B
Volume Ratio:1.47
T/O Rate:0.81%
Dividend:0.83
Dividend Rate:4.30%
EPS(TTM):0.8500
EPS(LYR):0.7600
ROE:15.58%
ROA:6.99%
PB:3.50
PE(LYR):25.39

Loading ...

Kenvue - FDA Grants Tylenol Three-year Exclusivity for New Otc Formulation

THOMSON REUTERS
·
Jul 25

Kenvue - Tylenol with Naproxen to be Available Soon at Major U.S. Retailers

THOMSON REUTERS
·
Jul 25

FDA Approves Tylenol® with Naproxen, the First and Only Over-the-counter Fixed-dose Combination of Acetaminophen (650 Mg) and Naproxen Sodium (220 Mg)

THOMSON REUTERS
·
Jul 25

Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)?

Simply Wall St.
·
Jul 24

Kenvue's Tylenol With Naproxen Combination Tablet Gets FDA Approval for Pain Relief

MT Newswires Live
·
Jul 24

US FDA - Approves Tylenol with Naproxen, First Otc Acetaminophen/naproxen Combination for 12-hour Pain Relief

THOMSON REUTERS
·
Jul 24

Kenvue Inc. Stock Falls Thursday, Still Outperforms Market

Dow Jones
·
Jul 24

Kenvue to Announce Second Quarter 2026 Results on August 6, 2026

THOMSON REUTERS
·
Jul 23

Kenvue is Maintained at Equal-weight by Barclays

Dow Jones
·
Jul 21

Barclays Adjusts Price Target on Kenvue to $19 From $18, Maintains Equalweight Rating

MT Newswires Live
·
Jul 21

Kenvue Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jul 17

Kenvue is Maintained at Neutral by UBS

Dow Jones
·
Jul 17

UBS Adjusts Price Target on Kenvue to $20 From $18, Maintains Neutral Rating

MT Newswires Live
·
Jul 16

Kenvue price target raised to $20 from $18 at UBS

TIPRANKS
·
Jul 16

Kenvue (KVUE) Faces Fresh Tylenol Lawsuit Risk On A Valuation Question

Simply Wall St.
·
Jul 14

PRESS Digest -wall Street Journal - July 14

Reuters
·
Jul 14

Kenvue Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 14

Kenvue/kimberly-clark Deal not in Jeopardy Despite Tylenol Ruling

Dow Jones
·
Jul 14

Top Midday Stories: Trump Says US to Be Guardian of Hormuz Strait; Meta to Invest Over $50 Billion in Louisiana Data Center Expansion

MT Newswires Live
·
Jul 13

Appeals court revives autism suits against Kenvue’s Tylenol, Bloomberg says

TIPRANKS
·
Jul 13